ArticleAnnals of medicine and surgery (2012)2026

Revuforj (revumenib): a novel menin inhibitor for relapsed or refractory acute leukemia.

Abdullah Imtiaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.